Cutler Group LP Eli Lilly & CO Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $105,038 - $123,826	-200 Reduced 15.38%	1,100 $4,000
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $4.61 Million - $6.35 Million	-10,600 Reduced 89.08%	1,300 $32,000
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $666,406 - $891,062	1,900 Added 19.0%	11,900 $2.8 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $341,693 - $401,302	-1,100 Reduced 9.91%	10,000 $1.54 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $96,465 - $112,401	-300 Reduced 2.63%	11,100 $1.83 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $177,888 - $202,722	600 Added 5.56%	11,400 $217,000
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $8.33 Million - $9.79 Million	-29,900 Reduced 73.46%	10,800 $311,000
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $6.59 Million - $8.2 Million	28,100 Added 223.02%	40,700 $529,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $2.16 Million - $2.68 Million	9,600 Added 320.0%	12,600 $143,000
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $1.26 Million - $1.63 Million	-7,000 Reduced 70.0%	3,000 $21,000
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $1.64 Million - $2.13 Million	10,000 New	10,000 $0
Q2 2020 Jul 22, 2020	SELL	$136.42 - $164.18 $136,420 - $164,180	-1,000 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $178,575 - $221,025	-1,500 Reduced 60.0%	1,000 $7,000
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $85,536 - $105,944	-800 Reduced 24.24%	2,500 $0
Q3 2019 Oct 28, 2019	BUY	$106.79 - $116.16 $85,432 - $92,928	800 Added 32.0%	3,300 $0
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $4.1 Million - $4.78 Million	-37,000 Reduced 93.67%	2,500 $1,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $3.24 Million - $3.81 Million	29,100 Added 279.81%	39,500 $204,000
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $211,800 - $237,280	-2,000 Reduced 16.13%	10,400 $144,000
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $257,580 - $321,930	3,000 Added 31.91%	12,400 $92,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $37,850 - $43,440	-500 Reduced 5.05%	9,400 $8,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $1.44 Million - $1.7 Million	-19,400 Reduced 66.21%	9,900 $9,000
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $32,776 - $35,156	-400 Reduced 1.35%	29,300 $136,000
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $2.29 Million - $2.54 Million	29,700	29,700 $210,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account